MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators

ABSTRACT: A severe lack of early diagnosis coupled with resistance to most available therapeutic options renders pancreatic cancer as a major clinical concern. The limited efficacy of current treatments necessitates the development of novel therapeutic strategies that are based on an understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales: Daoud, Afra Z., Mulholland, Eoghan J., Cole, Grace, McCarthy, Helen O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868851/
https://www.ncbi.nlm.nih.gov/pubmed/31752758
http://dx.doi.org/10.1186/s12885-019-6284-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868851/
https://www.ncbi.nlm.nih.gov/pubmed/31752758
http://dx.doi.org/10.1186/s12885-019-6284-y

Ejemplares similares